<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Optineurin (OPTN) is a multifunctional protein involved in vesicular trafficking, signal transduction and gene expression </plain></SENT>
<SENT sid="1" pm="."><plain>OPTN mutations were described in eight Japanese patients with familial and <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:hpo ids='HP_0007354'>amyotrophic lateral sclerosis</z:hpo> (FALS, SALS) </plain></SENT>
<SENT sid="2" pm="."><plain>OPTN-positive inclusions co-localising with TDP-43 were described in SALS and in FALS with SOD-1 mutations, potentially linking two pathologically distinct pathways of <z:mp ids='MP_0000938'>motor neuron degeneration</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>We have explored the abundance of OPTN inclusions using a range of antibodies in postmortem tissues from 138 cases and controls including <z:hpo ids='HP_0003745'>sporadic</z:hpo> and familial ALS, <z:e sem="disease" ids="C0751072" disease_type="Mental or Behavioral Dysfunction" abbrv="FTLD">frontotemporal lobar degeneration</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>) and a wide range of neurodegenerative proteinopathies </plain></SENT>
<SENT sid="4" pm="."><plain>OPTN-positive inclusions were uncommon and detected in only 11/32 (34%) of TDP-43-positive SALS spinal cord and 5/15 (33%) of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>-TDP </plain></SENT>
<SENT sid="5" pm="."><plain>Western blot of lysates from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>-TDP frontal cortex and TDP-43-positive SALS spinal cord revealed decreased levels of OPTN protein compared to controls (p &lt; 0.05), however, this correlated with decreased neuronal numbers in the brain </plain></SENT>
<SENT sid="6" pm="."><plain>Large OPTN inclusions were not detected in FALS with SOD-1 and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FUS</z:e> mutation, respectively, or in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FUS</z:e> cases </plain></SENT>
<SENT sid="7" pm="."><plain>OPTN-positive inclusions were identified in a few <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) cases but did not co-localise with tau and TDP-43 </plain></SENT>
<SENT sid="8" pm="."><plain>Occasional striatal neurons contained granular cytoplasmic OPTN immunopositivity in <z:e sem="disease" ids="C0020179" disease_type="Disease or Syndrome" abbrv="HD">Huntington's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) but were absent in spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 3 </plain></SENT>
<SENT sid="9" pm="."><plain>No OPTN inclusions were detected in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>-tau and Î±-synucleinopathy </plain></SENT>
<SENT sid="10" pm="."><plain>We conclude that OPTN inclusions are relatively rare and largely restricted to a minority of TDP-43 positive ALS and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>-TDP cases </plain></SENT>
<SENT sid="11" pm="."><plain>Our results do not support the proposition that OPTN inclusions play a central role in the pathogenesis of ALS, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e> or any other <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorder</z:e> </plain></SENT>
</text></document>